Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M414Revenue (TTM) $M187Net Margin (%)8.0Altman Z-Score2.1
Enterprise Value $M244EPS (TTM) $0.1Operating Margin %29.3Piotroski F-Score4
P/E(ttm)28.6Beneish M-Score-0.8Pre-tax Margin (%)18.4Higher ROA y-yN
Price/Book0.610-y EBITDA Growth Rate %2.1Quick Ratio2.0Cash flow > EarningsY
Price/Sales2.35-y EBITDA Growth Rate %-8.2Current Ratio2.0Lower Leverage y-yY
Price/Free Cash Flow7.7y-y EBITDA Growth Rate %-86.0ROA % (ttm)1.3Higher Current Ratio y-yN
Dividend Yield %2.0PEG--ROE % (ttm)2.0Less Shares Outstanding y-yN
Payout Ratio %56.0Shares Outstanding M161ROIC % (ttm)3.7Gross Margin Increase y-yN

Gurus Latest Trades with PDLI

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PDLI is held by these investors:



PDLI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GARCIA PETER SVice President, CFO 2017-03-24Buy25,000$1.9829.8view
GARCIA PETER SVice President, CFO 2016-08-09Buy10,000$3-14.33view
GARCIA PETER SVice President, CFO 2015-12-15Buy15,000$3.5-26.57view
Pietzke SteffenController and CAO 2015-12-07Buy20,590$3.64-29.4view
GARCIA PETER SVice President, CFO 2015-08-14Buy20,000$5.83-55.92view
SELICK HAROLD EDirector 2014-11-26Buy6,000$8.08-68.19view
Lindell Jody SDirector 2011-03-15Buy374$5.33-51.78view
LARSON CHRISTINE RVice President and CFO 2010-05-14Buy5,000$5.71-54.99view
LARSON CHRISTINE RVice President and CFO 2010-04-30Buy10,000$6.18-58.41view
KLEIN JOSEPH IIIDirector 2009-11-04Sell24,000$8.33-69.15view

Press Releases about PDLI :

Quarterly/Annual Reports about PDLI:

News about PDLI:

Articles On GuruFocus.com
Noden Pharma Notified of ANDA Filing for Tekturna® Jun 05 2017 
PDL BioPharma to Present at the Jefferies 2017 Healthcare Conference Jun 01 2017 
LENSAR® And PDL BioPharma Complete Strategic Financial Restructuring Of LENSAR May 11 2017 
PDL BioPharma Announces First Quarter 2017 Financial Results May 03 2017 
PDL BioPharma to Announce First Quarter 2017 Financial Results on May 3, 2017 Apr 26 2017 
PDL BioPharma Announces Settlement of Keytruda Patent Infringement Lawsuit with Merck Apr 24 2017 
PDL BioPharma to Hold Annual Meeting of Stockholders on June 9, 2017 Apr 06 2017 
8 High-Yield Stocks With Falling Prices Feb 21 2017 
Medical Companies Offer Good Value Opportunities Sep 16 2016 
Undervalued Companies With Growing EPS Apr 04 2016 

More From Other Websites
ETFs with exposure to PDL BioPharma, Inc. : June 20, 2017 Jun 20 2017
PDL BioPharma, Inc. :PDLI-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017 Jun 19 2017
PDL BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : PDLI-US : June 19, 2017 Jun 19 2017
Noden Pharma Notified of ANDA Filing for Tekturna® Jun 05 2017
PDL BioPharma to Present at the Jefferies 2017 Healthcare Conference Jun 01 2017
LENSAR® And PDL BioPharma Complete Strategic Financial Restructuring Of LENSAR May 11 2017
Edited Transcript of PDLI earnings conference call or presentation 3-May-17 8:30pm GMT May 06 2017
LENSAR® Receives FDA Clearances for Laser Cataract Platform Integration With OCULUS Pentacam®... May 05 2017
PDL BioPharma posts 1Q profit May 03 2017
PDL BioPharma Announces First Quarter 2017 Financial Results May 03 2017
Investor Network: PDL BioPharma, Inc. to Host Earnings Call May 03 2017
PDL BioPharma, Inc. – Value Analysis (NASDAQ:PDLI) : April 26, 2017 Apr 26 2017
PDL BioPharma to Announce First Quarter 2017 Financial Results on May 3, 2017 Apr 26 2017
PDL BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : PDLI-US : April 25,... Apr 25 2017
ETFs with exposure to PDL BioPharma, Inc. : April 24, 2017 Apr 24 2017
Sarepta Pops on Bullish Sentiment Around Duchenne Therapy, PDL Up on Merck Deal: Biotech Movers Apr 24 2017
PDL BioPharma to be paid $19.5 million by Merck to settle Keytruda patent suit Apr 24 2017
PDL BioPharma Announces Settlement of Keytruda Patent Infringement Lawsuit with Merck Apr 24 2017
PDL BioPharma to Hold Annual Meeting of Stockholders on June 9, 2017 Apr 06 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}